HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, L. Articles by Hunt, J. S. Search for Related Content PubMed PubMed Citation Articles by Miller, L. Articles by Hunt, J. S.

Regulation of TNF- Production in Activated Mouse Macrophages by Progesterone¹

Lance Miller and Joan S. Hunt^2,,*

Departments of ^* Anatomy and Cell Biology and Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
The purpose of this study was to investigate the relationships between macrophage production of TNF- and female hormones. Northern blot hybridization experiments showed that the female sex steroid hormone, progesterone, decreases steady state levels of TNF- mRNA in LPS-activated mouse macrophages (RAW 264.7 and ANA-1 cells) in vitro. The production of intracellular and secreted TNF- protein, as determined by ELISA, was decreased in both progesterone- and dexamethasone-treated, LPS-stimulated macrophages. Estrogen had no effect on expression of the TNF- gene in mouse macrophages and did not alter progesterone-mediated suppression. Additional experiments conducted to investigate the mechanism of action of progesterone showed that this hormone, like dexamethasone, elevates steady state mRNA levels of IB and increases the levels of IB protein that are translocated from the cytoplasm to the nucleus. Thus, progesterone is a potent inhibitor of steady state levels TNF- mRNA and TNF- protein production in activated macrophages and may achieve this result through effects on an inhibitor of NF-B.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Tumors of the breast and reproductive system rank second after tumors of the lung as the most common forms of cancer in women in the United States (1, 2, 3). Worldwide, cervical carcinoma is the leading cause of death by cancer among pregnant women (4). Macrophages are present in large numbers within the microenvironments of reproductive tissues and, when activated, could play an important role in host defense against tumors. The complex process of macrophage activation involves a series of function-enhancing steps induced by environmental signals that include various inflammatory cytokines and bacterial endotoxins such as LPS (5). Following activation, macrophages are capable of infiltrating tumors and releasing potent effector molecules such as TNF-, a powerful cytokine that can initiate both local and systemic antitumor activities (6). TNF- also has the ability to regulate tumor cell proliferation; in vitro studies have demonstrated both stimulation and inhibition of the growth of breast and ovarian cancer cells (7, 8, 9). Yet there is increasing evidence for the reciprocal pathway; hormones produced in and targeted to the female reproductive tract are major modulators of TNF- production in LPS-activated macrophages (10).

The transcription factor NF-B is a critical component of several signal transduction pathways, including those leading to TNF- synthesis (11). Activation of NF-B involves dissociation from inhibitory proteins, one of which is IB. Once dissociated, free NF-B is transported into the nucleus, where it can activate transcription of certain genes, particularly those involved in immune and inflammatory responses (12). Anti-inflammatory reagents such as corticosteroids induce IB gene and protein synthesis (13), whereas LPS, PMA, IL-1, and TNF- induce IB to dissociate from NF-B (14, 15, 16). The newly synthesized IB protein can either associate with free NF-B in the cytoplasm and inhibit its translocation to the nucleus or translocate to the nucleus and sequester free NF-B and promote the dissociation of DNA-bound NF-B, resulting in a decrease in cytokine production (11, 17).

The purpose of this study was to investigate the relationships between macrophage production of TNF- and female hormones so as to better understand immunity in women of child-bearing age. Our experiments show that the female sex steroid hormone, progesterone (P4), down-regulates the production of TNF- mRNA and intracellular as well as released TNF- protein. Like the effects of glucocorticoids, P4 increased levels of IB mRNA and increased the level of IB protein translocated from the cytoplasm to the nucleus in LPS-activated mouse macrophages, suggesting that the two steroid hormones may implement the same pathway leading to inhibition of TNF- synthesis.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Cells and culture conditions

The mouse macrophage-like cell line, RAW 264.7, which was purchased from American Type Culture Collection (Rockville, MD) and was used in most experiments, and the mouse macrophage cell line, ANA-1, a gift from Dr. E. J. Kovacs (Loyola University, Chicago, IL), were cultured at 37°C in 5% CO₂ in growth medium composed of phenol red-free MEM (Sigma, St. Louis, MO) containing 10% (v/v) FCS (HyClone, Logan, UT), 2 mM glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin (Sigma). For hormone treatment experiments, the FCS content was reduced to 1%.

TNF- protein quantitation by ELISA

RAW 264.7 cells grown in 100-mm tissue culture dishes were used for dose-response and time-course experiments, in which TNF- in the supernatant culture medium was measured using the Factor-Test-X mouse TNF- ELISA kit (Genzyme, Cambridge, MA) according to the manufacturer’s procedure. Recombinant mouse TNF- (Genzyme) was used to establish a standard curve. The cells (1 x 10⁷ cells/dish) were activated with 500 ng/ml of LPS (the lipid A-rich fraction II of LPS phenol extracted from Escherichia coli 0111:B4, a gift from David Morrison, Department of Microbiology, Immunology and Molecular Genetics) as described previously (18). This concentration of LPS was used throughout the study. In two types of experiments, RAW 264.7 cell cultures were incubated either with a single bolus of hormone(s) (Sigma) or with a hormone-containing time-release pellet(s) (Innovative Research of America, Sarasota, FL). In the bolus dose-response experiments, RAW 264.7 cells were exposed to 0, 0.003, 0.03, 0.3, or 3 µg/ml of 17ß-estradiol (E2),³ P4, dexamethasone (DEX), E2 plus P4, E2 plus DEX, or P4 plus DEX with or without LPS for 40 min. In the bolus time-course experiments, RAW 264.7 cells were exposed to 0 or 3 µg/ml of E2, P4, DEX, E2 plus P4, E2 plus DEX, or P4 plus DEX for 0–6 h with or without LPS. Control cultures consisted of cells cultured in medium alone or in medium with LPS containing a matching concentration (0.01%) of the vehicle, DMSO, that was used to solubilize the hormones. In the continuous release pellet experiments, dose responses were determined by incubating the RAW 264.7 cells with time-release pellets containing 0.001, 0.01, 0.1, 1, 10, 100, or 1000 µg of hormone/pellet of E2 or P4 alone or in combination for 48 h followed by an additional 6-h incubation with or without LPS. Time-course experiments used RAW 264.7 cells incubated for 48 h with a 100-µg pellet of E2 or P4 or with a combination of a 100-µg E2 pellet and a 100-µg P4 pellet followed by an additional incubation for 6, 12, or 24 h with or without LPS. TNF- concentrations in cellular lysates and culture medium were determined from RAW 264.7 cells exposed to medium alone or to medium containing DMSO (vehicle) as well as 3 µg/ml of P4 or DEX, with or without LPS collected after 30, 45, and 60 min and 6 h. Culture medium was collected, and cells were harvested in Tris-buffered saline (TBS), pelleted, and lysed in buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, and 0.6% octylphenoxy polyethoxy ethanol (Nonidet P-40) as described previously (19). Cell lysates and culture medium from experiments were collected and stored in microfuge tubes at -70°C until analyzed for TNF- protein.

Hormone quantitation by RIA assay

The concentrations of E2 and P4 present in the culture medium were monitored using Coat-A-Count RIA kits (Diagnostic Products, Los Angeles, CA) according to the manufacturer’s procedure.

Isolation of RNA and Northern blotting

Total RNA was isolated from RAW 264.7 and ANA-1 cells exposed to the treatments described above using TRIzol reagent according to the manufacturer’s instructions (Life Technologies, Grand Island, NY). Isolated RNA (10 µg/lane) was separated by electrophoresis on 1% agarose gels containing 2.2 M formaldehyde and transferred to nylon membranes according to the manufacturer’s instructions (Micron Separations, Westborough, MA). Prehybridization, hybridization, and posthybridization procedures were performed using Quik-Hyb hybridization solution as described by the manufacturer (Stratagene, La Jolla, CA). During the hybridization step, the membranes were incubated with ³²P-labeled cDNA probes specific for murine TNF-, IB, or glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA, each labeled by the random primer DNA labeling method (Stratagene) using [-³²P]dCTP (ICN Biomedicals, Costa Mesa, CA). The murine TNF- cDNA probe was a gift from Dr. C. Martens, Affymax Research Institute (Palo Alto, CA), the murine IB cDNA probe was a gift from Dr. I. M. Verma, The Salk Institute (San Diego, CA), and the murine G3PDH cDNA probe was a gift from Dr. R. W. Allen, American Red Cross Blood Services (St. Louis, MO) (20). The membranes probed with the TNF- cDNA were autoradiographed on Kodak XAR-5 film (Eastman Kodak, Rochester, NY) at -70°C with intensifying screens and later washed and reprobed, first with the IB and then with the G3PDH cDNA control probe. The autoradiographic TNF- and IB mRNA signals were quantitated by scanning densitometry and corrected relative to the G3PDH mRNA signal levels.

Isolation of cytoplasmic and nuclear extracts and Western blotting

Cytoplasmic and nuclear extracts were isolated according to methods described previously (19). Briefly, RAW 264.7 cells (1 x 10⁷ cells/dish) were exposed to 3 µg/ml P4 or DEX with or without LPS (500 ng/ml) for 5 or 15 min. Cells were harvested in TBS, pelleted, and lysed in a buffer containing 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, and 0.6% Nonidet P-40. Cells were centrifuged, and the nuclear pellet was isolated from the cytoplasmic extract supernatant and resuspended in buffer containing 20 mM HEPES (pH 7.9), 0.4 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 mM PMSF. The nuclear pellet mixture was incubated at 4°C for 15 min, and the nuclear extract was collected from the supernatant following a 5-min centrifugation. Cytoplasmic and nuclear extracts (25 µg/lane) were electrophoresed on 4 to 15% gradient SDS-PAGE gels and transferred to nitrocellulose (Schleicher and Schuell, Keene, NH). After electrophoretic protein transfer, nonspecific Ab binding sites on the nitrocellulose were blocked by incubation with 3% nonfat milk in Tris-buffered saline and 0.5% Tween-20 blocking buffer. The membranes were incubated with IB antiserum diluted in blocking buffer (1/2000) or with anti-NF-B (1/3000), and extracts were detected by chemiluminescence according to the manufacturer’s procedure (Pierce, Rockford, IL). The IB and NF-B antisera were gifts from N. Rice, Frederick Cancer Research and Development Center (Frederick, MD). The m.w. were determined with prestained standards (Bio-Rad, Richmond, CA).

Cell viability assay

Viabilities of RAW 264.7 and ANA-1 cells were determined in all experiments using the CellTiter 96 nonradioactive cell proliferation assay according to the manufacturer’s procedure (Promega, Madison, WI). This colorimetric assay measures the mitochondrial enzyme cleavage of the tetrazolium ring of 3-[4,5,-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium. A microplate reader (model MR5000, Dynatech, Chantilly, VA) was used to measure the absorbance at 570 nm of the blue-colored formazan products. Absorbance values from each hormone-treated group were compared with values for untreated and vehicle-treated controls to determine cell viability.

Statistical analysis

All methods that yielded numerical values were subjected to one-way analysis of variance and differences between individual means were determined using Duncan’s multiple range test. Each experiment was conducted in replicates of three for each treatment group. Results were analyzed using the SigmaStat program package (Jandel Scientific Software, San Rafael, CA).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Effects of continuous exposure to E2 and P4 on TNF- mRNA levels in LPS-stimulated macrophages

The ability of female steroid hormones to modulate synthesis of TNF- was first tested by determining the effects of E2 and/or P4 on the expression of TNF- mRNA in LPS-activated macrophages. RAW 264.7 cells were pretreated with E2 and/or P4 using 100 µg of E2 and/or 100 µg of P4 time-release pellet(s) for 48 h followed by a 6- or 24-h exposure to LPS in the continued presence of the pellets. As shown in Figure 1, A and B, steady state levels of TNF- mRNA in LPS-activated RAW 264.7 cells exposed to P4 or to E2 plus P4 were consistently lower than levels in LPS-activated RAW 264.7 cells that were cultured in medium alone. This decrease was observed after 6 h and after 24 h. Shorter exposures for 1 or 3 h also caused a decrease in the steady state levels of TNF- mRNA in LPS-activated RAW 264.7 cells exposed to P4 or to E2 plus P4 (data not shown). E2 did not affect TNF- mRNA steady state levels (see Fig. 1, A and B) or relieve the suppression induced by P4. To be certain that this phenomenon was not unique to the RAW 264.7 cells, we tested the ANA-1 cells using identical techniques, and the results were essentially the same as those obtained using the RAW 264.7 cells (data not shown).

View larger version (48K): [in this window] [in a new window]   FIGURE 1. Analysis by Northern blot hybridization of TNF- mRNA expression study in activated macrophages exposed to E2 and/or P4. Total RNA was isolated from RAW 264.7 macrophages cultured in medium alone or in medium containing time-release pellet(s) (100 µg of E2 or P4) for 48 h followed by 6-h (A) or 24-h (B) exposure to LPS or not (control). Equal amounts (10 µg) of isolated total RNA were electrophoretically separated, transferred to nylon membranes, and hybridized with a 32P-labeled mouse TNF- probe. After autoradiography and densitometric analysis, the nylon membranes were washed, reprobed with a [32P]G3PDH cDNA, and processed for Northern blot analysis. After densitometric analysis, the autoradiographic TNF- mRNA signals were corrected relative to the G3PDH mRNA signal levels (see Materials and Methods). The results shown represent one of two separate experiments that had essentially the same outcome.

Effects of P4 on TNF- production by LPS-stimulated macrophages

Having learned that P4, but not estrogen, decreases steady state levels of TNF- mRNA, experiments were performed to determine whether E2 and/or P4 modulated TNF- protein production or release by LPS-activated macrophages. Cell culture media were assayed for TNF- protein following exposure to activators and various hormones using a commercial ELISA. As shown in Figure 2, RAW 264.7 macrophages displayed a dose-dependent decrease in TNF- production following a 48-h pre-exposure to pellets containing various concentrations of P4. After 6 h of subsequent exposure to LPS, the concentration of TNF- in the culture media of activated RAW 246.7 macrophages was decreased by 68 and 81% in cells exposed to P4 from time-release pellets containing 100 and 1000 µg of P4, respectively, compared with that in macrophages exposed to LPS alone. By contrast, E2 from pellets containing up to 1000 µg of the hormone did not affect RAW 264.7 cell production of TNF- compared with that by the cell cultures stimulated with LPS alone (Fig. 2).

View larger version (32K): [in this window] [in a new window]   FIGURE 2. Dose-response study of the effects of E2 and/or P4 on TNF- production by LPS-activated macrophages. RAW 264.7 cells were cultured in medium alone or in medium containing 0.001, 100, or 1000 µg of E2; 0.001, 100, or 1000 µg of P4; or a combination of 0.001, 100, or 1000 µg of E2 plus 0.001, 100, or 1000 µg of P4 time-released pellet(s) for 48 h followed by 6-h exposure to LPS or no treatment (control). Culture supernatants were assayed for TNF- protein by ELISA. The results shown (mean ± SE of triplicate determinations) represent one of two separate experiments that had essentially the same results. * indicates p < 0.01 compared with LPS alone control.

View larger version (33K): [in this window] [in a new window]   FIGURE 3. Time-course study of the effects of E2 and/or P4 on TNF- production by activated macrophages. RAW 264.7 cells were cultured in medium alone or in medium containing 100 µg of E2, 100 µg of P4, or 100 µg of E2 plus 100 µg of P4 time-release pellet(s) for 48 h followed by exposure for 6, 12, or 24 h to LPS or no treatment (control). Culture supernatants were assayed for TNF- protein by ELISA. The results shown (mean ± SE of triplicate determinations) represent one of two separate experiments that had essentially the same results. * indicates p < 0.01 compared with LPS alone control.

Regulation of IB mRNA expression in unstimulated macrophages by P4

Glucocorticoids are known to inhibit TNF- synthesis by stimulating the production of IB (13). Therefore, additional experiments were performed to learn whether P4 might act in a similar manner. To determine the effects of E2, P4, and the glucocorticoid, DEX, on steady state levels of IB mRNA in unstimulated macrophages, RAW 264.7 cells were exposed for 25, 40, or 55 min to a single bolus of 3 µg/ml of E2, P4, DEX, or combinations of the steroid hormones. Figure 4 and Table II show that unstimulated RAW 264.7 cells exposed to P4 and/or DEX displayed higher steady state levels of IB mRNA and that the increase over constitutive expression was maximal at 40 min. The presence of E2 did not affect IB mRNA expression and did not change the ability of P4 and DEX to increase steady state levels (data not shown).

View larger version (41K): [in this window] [in a new window]   FIGURE 4. Time-course study of the effects of P4 and/or DEX on IB mRNA expression by unstimulated macrophages exposed to P4 and/or DEX using Northern blot hybridization. Total RNA was isolated from RAW 264.7 macrophages cultured for 25, 40, or 55 min in medium alone or in medium containing DMSO (vehicle) as well as 3 µg/ml P4 and/or DEX. Equal amounts (10 µg) of isolated total RNA were electrophoretically separated, transferred to nylon membranes, and hybridized with a 32P-labeled mouse IB probe. After autoradiography and densitometric analysis, the nylon membranes were washed and reprobed with a [32P]G3PDH cDNA. After densitometric analysis the autoradiographic IB mRNA signals were corrected relative to the G3PDH mRNA signal levels (see Materials and Methods). The results shown represent one of two separate experiments, which had essentially the same outcome.

View this table: [in this window] [in a new window]   Table II. Northern blot hybridization study of the effects of P4 and/or DEX on IB mRNA expression by unstimulated RAW 264.7 macrophages exposed for 40 min to either medium alone, medium containing DMSO (vehicle), or medium containing 3 µg/ml of P4 and/or DEX1

Regulation of IB mRNA expression in LPS-stimulated macrophages by P4

RAW 264.7 cells were exposed to various concentrations of P4 and/or DEX (bolus form) in the presence of LPS for 40 min. As shown in Figure 5A, the expression of IB mRNA in LPS-activated RAW 264.7 cells given 3 µg/ml of P4 and/or DEX displayed an increase in the steady state levels of IB mRNA compared with those in cells treated with medium alone or vehicle plus LPS.

View larger version (40K): [in this window] [in a new window]   FIGURE 5. Northern blot hybridization study of the effects of P4 and/or DEX on IB mRNA expression (A) and TNF- expression (B) by unstimulated and LPS-stimulated macrophages exposed to P4 and/or DEX. Total RNA was isolated from RAW 264.7 macrophages cultured for 40 min in medium alone or in medium containing DMSO (vehicle) as well as 3 µg/ml of P4 and/or DEX. Equal amounts (10 µg) of isolated total RNA were electrophoretically separated, transferred to nylon membranes, and hybridized with a 32P-labeled mouse IB probe. After autoradiography and densitometric analysis, the nylon membranes were washed, reprobed with [32P]G3PDH cDNA, and processed for Northern blot analysis. After densitometric analysis, the autoradiographic TNF- mRNA signals were corrected relative to the G3PDH mRNA signal (see Materials and Methods). The results shown represent one of two separate experiments of each type that had essentially the same outcome.

View this table: [in this window] [in a new window]   Table III. TNF- concentrations in cell lysate and culture medium collected over time from RAW 264.7 macrophages cultured in medium alone, medium containing DMSO (vehicle), or in medium containing 3 µg/ml of P4 or DEX with or without LPS1

Regulation of IB protein expression in LPS-stimulated macrophages by P4

The inhibitor protein IB maintains the NF-B transcription factor in an inactive form in both the cytoplasm and the nucleus (12, 13, 17) of cells and prevents NF-B-induced transcription of various cytokine genes, including TNF-. To investigate the effects of P4 on the expression and the cytoplasm to nucleus translocation of IB and NF-B over time within LPS-stimulated macrophages, cytoplasmic and nuclear extracts were isolated from RAW 264.7 cells exposed to 3 µg/ml of P4 or DEX with or without LPS for 5 to 15 min (Fig. 6). Cytoplasmic IB and NF-B protein expression was not changed after 5 and 15 min in unstimulated and LPS-stimulated macrophages exposed to P4, DEX, or vehicle. However, after 5 and 15 min, IB and NF-B proteins were observed in the nuclear extracts of LPS-stimulated macrophages treated with P4, DEX, or vehicle, but not in unstimulated macrophages. The early translocation of IB and NF-B proteins from the cytoplasm to the nucleus in LPS-stimulated macrophages was profoundly changed by exposure to P4 and DEX, as shown by elevated levels of IB and NF-B proteins in the nucleus of LPS-stimulated macrophages treated with P4 or DEX compared with those in LPS-stimulated macrophages treated with vehicle.

View larger version (30K): [in this window] [in a new window]   FIGURE 6. Western blot study of the effects of P4 or DEX on IB and NF-B protein expression in the cytoplasmic and nuclear extracts of unstimulated and LPS-stimulated macrophages exposed to P4 or DEX. Cytoplasmic or nuclear extracts (25 µg/lane) were electrophoresed on 4 to 15% gradient SDS-polyacrylamide gels and transferred to nitrocellulose membranes. After electrophoretic protein transfer, nonspecific Ab binding sites on the membranes were blocked by incubation with 3% nonfat milk in TBS and 0.5% Tween-20 blocking buffer. The nitrocellulose membranes were incubated with IB antiserum diluted in blocking buffer, washed, and incubated with secondary antiserum in blocking buffer followed by a final wash. The x-ray film was exposed to the nitrocellulose membranes, and protein extracts were detected by chemiluminescence. Nitrocellulose membranes were washed and reprobed with NF-B antiserum and processed for Western blot analysis. The m.w. were determined with prestained standards. The results shown represent one of two separate experiments of each type that had essentially the same outcome.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

Analysis by Northern blot hybridization was used to investigate the effect of hormones on TNF- mRNA expression in LPS-activated macrophages. The dramatic reduction in steady state levels of TNF- mRNA achieved by P4 in these experiments, which included the testing of two different macrophage cell lines, supports the postulate that P4 inhibits TNF- gene transcription. Also, the P4-mediated suppression of cellular and released TNF- protein production observed in ELISA assays indicates that P4 is a potent modulator of post-transcriptional events, not just transcription.

Identifying the effects of P4 on macrophage TNF- mRNA required long term exposure to the hormone, which was accomplished using time-release pellets, while TNF- protein levels were decreased early after activation. Thus, mouse macrophages may not be sensitive to transient alterations in steroid concentrations but might, instead, be most profoundly influenced in situations such as pregnancy where P4 levels are continuously high. This contrasts sharply with our observation that short term exposure to pharmacologic levels of P4 inhibits iNOS gene activity and nitric oxide production by IFN-- plus LPS-activated mouse macrophages (22). However, it is known that different activation pathways lead to the production of TNF- and nitric oxide by macrophages (23, 24).

We observed no effects of estrogen on macrophage production of TNF-. This result differs from those of other experiments showing that E2 can either increase or decrease TNF- gene expression in a dose-dependent manner in human monocytes or rat peritoneal macrophages in vitro (25, 26). The results shown here indicate that high doses of E2 do not alter TNF- gene activity nor does E2 affect the P4-mediated inhibition of TNF- mRNA steady state levels. Differences in our results compared with those of other reports could be attributed to differences in species, culture techniques, or experimental design.

In general, P4 appears to have anti-inflammatory properties. Our observations of its effects on TNF- are consistent with reports from other investigators who have shown that pharmacologic doses of P4 suppress IL-1 mRNA expression (27) and IL-1 cytokine release (28) and T cell activation (29) and with our own finding that P4 inhibits inducible nitric oxide synthase gene promoter activity, inducible nitric oxide synthase mRNA expression, and nitric oxide production in IFN-- and LPS-activated mouse macrophages (22). Additionally, our finding of a P4-mediated decrease in TNF- production by LPS-activated mouse macrophages is in agreement with previous observations showing that P4 decreases TNF- release from rat peritoneal macrophages (26).

Glucocorticoid-mediated suppression of macrophage function has been reported to involve the induction of IB gene transcription, a subsequent increase in IB protein synthesis, and binding of IB to free nuclear NF-B in the cytoplasm (30). The results of our study indicate that P4 at the same concentration as DEX increases IB mRNA steady state levels in mouse macrophages. The mechanism by which DEX induces the increase in IB gene activity and IB protein production involves binding of the glucocorticoid to a glucocorticoid receptor expressed by macrophages (13). P4 is also known to bind to glucocorticoid receptor in mouse macrophages (31, 32). Our finding of a P4-mediated increase in the level of IB protein moving from the cytoplasm to the nucleus in LPS-activated macrophages is consistent with reports that IB can move freely into the nucleus, reassociate with nuclear NF-B, and inhibit DNA binding (17, 33). It is, therefore, this signaling pathway that might explain our observation of a P4-mediated increase in the IB mRNA steady state levels and IB and NF-B protein translocation into the nucleus and the eventual reduction in TNF- mRNA and cellular and released TNF- protein production. More experiments are needed to understand the P4- and DEX-mediated increases in both IB and NF-B proteins in macrophage nuclei, including studies on associations between the proteins and the effects on DNA binding. Further studies on bulk protein synthesis are needed to determine whether P4 alters the expression of other inflammatory mediators and noninflammatory proteins.

Although cross-binding of P4 to glucocorticoid receptors could explain our results, it is possible that P4-mediated regulation of IB mRNA abundance could involve binding of P4 to unique P4 receptors. Although P4 receptors have not been identified in mouse macrophages by reverse transcriptase-PCR using primers developed from reproductive tissue (22), this does not preclude the possibility of a mouse macrophage-specific PR that will bind to P4 and induce a classical steroid receptor-mediated increase in IB gene transcription. A recent report has shown that human peritoneal macrophages express PR, and that physiologic concentrations of P4 increase the synthesis of vascular endothelial growth factor protein after activation by LPS (34). The outcome would be the same, i.e., down-regulation of TNF- gene expression.

In summary, the results of our study demonstrate that P4 is a potent inhibitor of macrophage TNF- gene activity and TNF- protein production. This P4-mediated suppressive effect on TNF- production lends support to the concept that female sex steroid hormones such as P4 are capable of profoundly altering the outcome of an immune response by regulating macrophage activation and production of inflammatory cytokines in tissues proximal to the production of P4.

	Acknowledgments

 
We thank Drs. Stephen W. Russell, William J. Murphy, Elizabeth J. Kovacs, Christine Martens, Tsuneo Suzuki, I. M. Verma, Nancy Rice, and Robert W. Allen for generously providing cell lines and reagents.

	Footnotes

 
¹ This work was supported by National Institutes of Health Grant HD24212 (to J.S.H.) and a National Institutes of Health core grant to the Kansas Mental Retardation Research Center (HD02528).

² Address correspondence and reprint requests to Dr. Joan S. Hunt, Department of Anatomy and Cell Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7400. E-mail address:

³ Abbreviations used in this paper: E2, 17ß-estradiol; P4, progesterone; DEX, dexamethasone; G3PDH, glyceraldehyde-3-phosphate dehydrogenase.

Received for publication February 11, 1997. Accepted for publication January 21, 1998.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Tortolero-Luna, G., M. F. Mitchell. 1995. The epidemiology of ovarian cancer. J. Cell. Biochem. 23:(Suppl.):200.
2. Schottenfeld, D.. 1995. Epidemiology of endometrial neoplasia. J. Cell. Biochem. 23:(Suppl.):151.
3. Titcomb, C. L.. 1990. Breast cancer and pregnancy. Hawaii Med. J. 49:18.[Medline]
4. Griep, A. E., P. F. Lambert. 1994. Role of papillomavirus oncogenes in human cervical cancer: transgenic animal studies. Proc. Soc. Exp. Biol. Med. 206:24.[Medline]
5. Adams, D.. 1992. Macrophage activation. I. M. Roitt, and P. J. Delves, eds. Encyclopedia of Immunology 1020. Academic Press, New York.
6. Nathan, C.. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
7. Jeoung, D. I., B. Tang, M. Sonenberg. 1995. Effects of tumor necrosis factor- on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J. Biol. Chem. 270:18367.[Abstract/Free Full Text]
8. Rocker, D., A. David, U. A. Liberman, O. Garach-Jehoshua, R. Koren. 1994. 1,25-Dihydroxyvitamin D₃ (1,25(OH)₂D₃) on the cytotoxic action of TNF on human breast cancer cells. Mol. Cell. Endocrinol. 106:157.[Medline]
9. Adashi, E. Y., C. E. Resnick, C. S. Croft, D. W. Payne. 1989. Tumor necrosis factor inhibits gonadotropin hormonal action in nontransformed ovarian granulosa cells: a modulatory noncytotoxic property. J. Biol. Chem. 264:11591.[Abstract/Free Full Text]
10. Shanker, G., M. Sorci-Thomas, M. R. Adams. 1994. Estrogen modulates the expression of tumor necrosis factor mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lymphokine Cytokine Res. 13:377.[Medline]
11. Zuckerman, S. H., G. F. Evans. 1992. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell. Immunol. 140:513.[Medline]
12. Chiao, P. J., S. Miyamoto, I. M. Verma. 1994. Autoregulation of IB activity. Biochemistry 91:28.
13. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, Jr A. S. Baldwin. 1995. Role of transcriptional activation of IB in mediation of immunosuppression by glucocorticoids. Science 270:283.[Abstract/Free Full Text]
14. Muroi, M., Y. Muroi, N. Ito, N. R. Rice, T. Suzuki. 1995. Effects of protease inhibitors on LPS-mediated activation of mouse macrophage cell line (J774). J. Endotoxin Res. 2:337.
15. Grandison, L., G. P. Nolan, D. W. Pfaff. 1994. Activation of the transcription factor NF-B in GH₃ pituitary cells. Mol. Cell. Endocrinol. 106:9.[Medline]
16. Beg, A. A., T. S. Finco, P. V. Nantermet, Jr A. S. Baldwin. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IB: a mechanism for NF-B activation. Mol. Cell. Biol. 13:3301.[Abstract/Free Full Text]
17. Zabel, U., T. Henkel, M. S. Silva, P. A. Baeuerle. 1993. Nuclear uptake control of NF-B by MAD-3, an I kappa B protein present in the nucleus. EMBO J. 12:201.[Medline]
18. Morrison, D. C., L. Leive. 1975. Fractions of lipopolysaccharide from Escherichia coli 0111:B4 prepared by two extractions procedures. J. Biol. Chem. 250:2911.[Abstract/Free Full Text]
19. Schreiber, E., P. Matthias, M. M. Muller, W. Schaffner. 1989. Rapid detection of octamer binding proteins with ‘mini-extracts,’ prepared from a small number of cells. Nucleic Acids Res. 17:6419.[Free Full Text]
20. Allen, R. W., K. A. Trach, J. A. Hoch. 1987. Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 262:649.[Abstract/Free Full Text]
21. Miller, L., J. S. Hunt. 1996. Sex steroid hormones and macrophage function. Life Sci. 59:1.[Medline]
22. Miller, L., E. W. Alley, W. J. Murphy, S. W. Russell, J. S. Hunt. 1996. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide in murine macrophages. J. Leukocyte Biol. 59:442.[Abstract]
23. Orlicek, S. L., E. Meals, B. K. English. 1996. Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages. J. Infect. Dis. 174:638.[Medline]
24. Hirohashi, N., D. C. Morrison. 1996. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 64:1011.[Abstract]
25. Ralston, S. H., R. Graham, G. Russell, M. Gowen. 1990. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res 5:983.[Medline]
26. Chao, T.-C., P. J. Van Alten, J. A. Greager, R. J. Walter. 1995. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell. Immunol. 160:43.[Medline]
27. Polan, M. L., J. Loukides, P. Nelson, S. Carding, M. Diamond, A. Walsh, K. Bottomly. 1989. Progesterone and estradiol modulate interleukin-1ß messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab. 69:1200.[Abstract/Free Full Text]
28. Polan, M. L., A. Daniele, A. Kuo. 1988. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil. Steril. 49:964.[Medline]
29. Szekeres-Bartho, J.. 1992. Immunosuppression by Progesterone in Pregnancy 4. CRC Press, Boca Raton, FL.
30. Beg, A. A., Jr A. S. Baldwin. 1993. The IB proteins: multifunctional regulators of Rel/NF-B transcription factors. Genes Dev. 7:2064.[Free Full Text]
31. Von der Ahe, D., S. Janich, C. Scheidereit, R. Renkawitz, G. Schutz, M. Beato. 1985. Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature 313:706.[Medline]
32. Cuchacovich, M., W. Rosa, M. Mena, C. Vanenzuela, H. Gatica, A. N. Tchernitchin. 1991. Intraarticular progesterone inhibits [³H]-dexamethasone binding to synovial cells from patients with rheumatoid arthritis. J. Rheumatol. 18:962.[Medline]
33. Cressman, D. E., R. Taub. 1993. IB can localize in the nucleus but shows no direct transactivation potential. Oncogene 8:2567.[Medline]
34. McLaren, J., A. Prentice, D. S. Charnock-Jones, S. A. Millican, K. H. Muller, A. M. Sharkey, S. K. Smith. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98:482.[Medline]

This article has been cited by other articles:

				C. R. Mendelson Minireview: Fetal-Maternal Hormonal Signaling in Pregnancy and Labor Mol. Endocrinol., July 1, 2009; 23(7): 947 - 954. [Abstract] [Full Text] [PDF]

				D. B. Hardy, B. A. Janowski, C.-C. Chen, and C. R. Mendelson Progesterone Receptor Inhibits Aromatase and Inflammatory Response Pathways in Breast Cancer Cells via Ligand-Dependent and Ligand-Independent Mechanisms Mol. Endocrinol., August 1, 2008; 22(8): 1812 - 1824. [Abstract] [Full Text] [PDF]

				M. E. Corrigan, J. S. Drouillard, M. F. Spire, D. A. Mosier, J. E. Minton, J. J. Higgins, E. R. Loe, B. E. Depenbusch, and J. T. Fox Effects of melengestrol acetate on the inflammatory response in heifers challenged with Mannheimia haemolytica J Anim Sci, July 1, 2007; 85(7): 1770 - 1779. [Abstract] [Full Text] [PDF]

				M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF]

				D. B. Hardy, B. A. Janowski, D. R. Corey, and C. R. Mendelson Progesterone Receptor Plays a Major Antiinflammatory Role in Human Myometrial Cells by Antagonism of Nuclear Factor-{kappa}B Activation of Cyclooxygenase 2 Expression Mol. Endocrinol., November 1, 2006; 20(11): 2724 - 2733. [Abstract] [Full Text] [PDF]

				X. Li, L. Strauss, A. Kaatrasalo, A. Mayerhofer, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen Transgenic Mice Expressing P450 Aromatase as a Model for Male Infertility Associated with Chronic Inflammation in the Testis Endocrinology, March 1, 2006; 147(3): 1271 - 1277. [Abstract] [Full Text] [PDF]

				B. Antus, S. Liu, Y. Yao, H. Zou, E. Song, J. Lutz, and U. Heemann Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats Nephrol. Dial. Transplant., February 1, 2005; 20(2): 329 - 335. [Abstract] [Full Text] [PDF]

				C. P. Lambert, M. G. Flynn, D. H. Sullivan, and W. J. Evans Effects of Megestrol Acetate on Circulating Interleukin-15 and Interleukin-18 Concentrations in Healthy Elderly Men J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M855 - M858. [Abstract] [Full Text] [PDF]

				K. C. Lambert, E. M. Curran, B. M. Judy, D. B. Lubahn, and D. M. Estes Estrogen receptor-{alpha} deficiency promotes increased TNF-{alpha} secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro J. Leukoc. Biol., June 1, 2004; 75(6): 1166 - 1172. [Abstract] [Full Text] [PDF]

				V. Paharkova-Vatchkova, R. Maldonado, and S. Kovats Estrogen Preferentially Promotes the Differentiation of CD11c+ CD11bintermediate Dendritic Cells from Bone Marrow Precursors J. Immunol., February 1, 2004; 172(3): 1426 - 1436. [Abstract] [Full Text] [PDF]

				M. P.B. Wijayagunawardane, C. Gabler, G. Killian, and A. Miyamoto Tumor Necrosis Factor {alpha} in the Bovine Oviduct During the Estrous Cycle: Messenger RNA Expression and Effect on Secretion of Prostaglandins, Endothelin-1, and Angiotensin II Biol Reprod, October 1, 2003; 69(4): 1341 - 1346. [Abstract] [Full Text] [PDF]

				T. A. Phillips, J. Ni, and J. S. Hunt Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas J. Leukoc. Biol., July 1, 2003; 74(1): 81 - 87. [Abstract] [Full Text] [PDF]

				J. F. Kuebler, Y. Yokoyama, D. Jarrar, B. Toth, L. W. Rue III, K. I. Bland, P. Wang, and I. H. Chaudry Administration of Progesterone After Trauma and Hemorrhagic Shock Prevents Hepatocellular Injury Arch Surg, July 1, 2003; 138(7): 727 - 734. [Abstract] [Full Text] [PDF]

				J. A.Z. Loudon, C. L. Elliott, F. Hills, and P. R. Bennett Progesterone Represses Interleukin-8 and Cyclo-Oxygenase-2 in Human Lower Segment Fibroblast Cells and Amnion Epithelial Cells Biol Reprod, July 1, 2003; 69(1): 331 - 337. [Abstract] [Full Text] [PDF]

				J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]

				K. A. N. Messingham, S. A. Heinrich, and E. J. Kovacs Estrogen restores cellular immunity in injured male mice via suppression of interleukin-6 production J. Leukoc. Biol., December 1, 2001; 70(6): 887 - 895. [Abstract] [Full Text] [PDF]

				N. Rohleder, N. C. Schommer, D. H. Hellhammer, R. Engel, and C. Kirschbaum Sex Differences in Glucocorticoid Sensitivity of Proinflammatory Cytokine Production After Psychosocial Stress Psychosom Med, November 1, 2001; 63(6): 966 - 972. [Abstract] [Full Text] [PDF]

				C. W. Roberts, W. Walker, and J. Alexander Sex-Associated Hormones and Immunity to Protozoan Parasites Clin. Microbiol. Rev., July 1, 2001; 14(3): 476 - 488. [Abstract] [Full Text] [PDF]

				M. I. Garcia-Lloret, B. Winkler-Lowen, and L. J. Guilbert Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-{alpha}. A model for hematogenous initiation of placental inflammations J. Leukoc. Biol., December 1, 2000; 68(6): 903 - 908. [Abstract] [Full Text]

				N. Isowa, S. H. Keshavjee, and M. Liu Role of microtubules in LPS-induced macrophage inflammatory protein-2 production from rat pneumocytes Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1075 - L1082. [Abstract] [Full Text] [PDF]

				L. L. Reznikov, B. D. Shames, H. A. Barton, C. H. Selzman, G. Fantuzzi, S.-H. Kim, S. M. Johnson, and C. A. Dinarello Interleukin-1beta deficiency results in reduced NF-kappa B levels in pregnant mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R263 - R270. [Abstract] [Full Text] [PDF]

				K. T. Iida, H. Shimano, Y. Kawakami, H. Sone, H. Toyoshima, S. Suzuki, T. Asano, Y. Okuda, and N. Yamada Insulin Up-regulates Tumor Necrosis Factor-alpha Production in Macrophages through an Extracellular-regulated Kinase-dependent Pathway J. Biol. Chem., August 24, 2001; 276(35): 32531 - 32537. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, L. Articles by Hunt, J. S. Search for Related Content PubMed PubMed Citation Articles by Miller, L. Articles by Hunt, J. S.